Impact of CD39 Expression on CD4+ T Lymphocytes and 6q Deletion on Outcome of Patients With Chronic Lymphocytic Leukemia

ConclusionCD39 expression on CD4+Tcells and del 6q act as prognostic markers in CLL. Blocking or inhibition of CD39 may be a target for new immune therapy for CLL.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research